CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current Assets:
Cash and cash equivalents	$ 86,516	$ 115,432
Restricted cash	80,848	133,597
Accounts receivable, less allowance for doubtful accounts of $3,246 and $3,731 at December 31, 2015 and March 31, 2016, respectively	446,514	428,644
Short-term investments (restricted investments of $277,556 and $268,887 at December 31, 2015 and March 31, 2016, respectively)	329,278	322,339
Pharmaceutical inventory	55,870	50,749
Other current assets (restricted deposits of $27,752 and $29,240 at December 31, 2015 and March 31, 2016, respectively)	67,828	46,921
Total Current Assets	1,066,854	1,097,682
Property and equipment, net	174,805	174,745
Restricted long-term investments	7,529	3,826
Deferred income taxes	27,313	26,836
Other long-term assets	20,566	11,207
Goodwill	634,474	621,390
Other intangible assets, net	128,012	133,374
Total Assets	2,059,553	2,069,060
Current Liabilities:
Accounts payable	82,620	86,484
Accrued liabilities	152,516	139,726
Short-term contingent consideration	90,541	91,623
Medical claims payable	211,247	250,449
Other medical liabilities	138,350	136,939
Current maturities of long-term debt and capital lease obligations	22,559	19,014
Total Current Liabilities	697,833	724,235
Long-term debt and capital lease obligations	231,980	238,295
Tax contingencies	13,123	12,677
Long-term contingent consideration	2,863	803
Deferred credits and other long-term liabilities	20,719	20,930
Total Liabilities	966,518	996,940
Redeemable non-controlling interest	$ 6,091	$ 5,937
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized - 10,000 shares at December 31, 2015 and March 31, 2016 - Issued and outstanding - none
Other Stockholders' Equity:
Additional paid-in capital	$ 1,140,699	$ 1,124,013
Retained earnings	1,224,547	1,211,310
Accumulated other comprehensive loss	(24)	(262)
Ordinary common stock in treasury, at cost, 26,648 shares and 26,791 shares at December 31, 2015 and March 31, 2016, respectively	(1,278,793)	(1,269,391)
Total Stockholders' Equity	1,086,944	1,066,183
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity	2,059,553	2,069,060
Ordinary common stock
STOCKHOLDERS' EQUITY
Common stock	$ 515	$ 513
Multi-Vote common stock
STOCKHOLDERS' EQUITY
Common stock